These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
4. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis]. Wuillemin WA; Solenthaler M Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317 [TBL] [Abstract][Full Text] [Related]
5. [Homocysteine. The cardiovascular risk factor of the next millennium?]. Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543 [TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Haynes WG Cardiovasc Drugs Ther; 2002 Sep; 16(5):391-9. PubMed ID: 12652108 [TBL] [Abstract][Full Text] [Related]
7. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related]
8. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12]. Alemán G; Tovar AR; Torres N Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110 [TBL] [Abstract][Full Text] [Related]
9. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. McKinley MC Proc Nutr Soc; 2000 May; 59(2):221-37. PubMed ID: 10946791 [TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia, atherosclerosis and thrombosis. Cattaneo M Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987 [TBL] [Abstract][Full Text] [Related]
11. [Public health control of hyperhomocysteinemia and its consequences]. Czeizel E; Kalina A Orv Hetil; 2003 Oct; 144(40):1981-9. PubMed ID: 14626640 [TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease. Cattaneo M Int J Clin Lab Res; 1997; 27(3):139-44. PubMed ID: 9352375 [TBL] [Abstract][Full Text] [Related]
13. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Lanska DJ Handb Clin Neurol; 2010; 95():445-76. PubMed ID: 19892133 [TBL] [Abstract][Full Text] [Related]
15. Homocysteine and arteriosclerosis: established risk factor or new illusion? Djuric D; Wisotzki R; Mitrovic V Am J Ther; 2000 Nov; 7(6):381-7. PubMed ID: 11304646 [TBL] [Abstract][Full Text] [Related]
16. [Group B vitamins as new variables related to the cardiovascular risk]. Granieri M; Bellisarii FI; De Caterina R Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726 [TBL] [Abstract][Full Text] [Related]
17. Homocysteine-lowering trials for prevention of heart disease and stroke. Clarke R Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274 [TBL] [Abstract][Full Text] [Related]
19. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases]. Milosević-Tosić M; Borota J Med Pregl; 2002; 55(9-10):385-91. PubMed ID: 12584890 [TBL] [Abstract][Full Text] [Related]